273 related articles for article (PubMed ID: 21069333)
1. Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?
Liapi E; Geschwind JF
Cardiovasc Intervent Radiol; 2011 Feb; 34(1):37-49. PubMed ID: 21069333
[TBL] [Abstract][Full Text] [Related]
2. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
4. Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
Duan F; Wang EQ; Lam MG; Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Kuo WT; Hofmann LV; Sze DY
Radiology; 2016 Feb; 278(2):612-21. PubMed ID: 26334787
[TBL] [Abstract][Full Text] [Related]
5. Chemoembolization for primary and metastatic liver cancer.
Liapi E; Geschwind JF
Cancer J; 2010; 16(2):156-62. PubMed ID: 20404613
[TBL] [Abstract][Full Text] [Related]
6. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
7. Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma.
Nouri YM; Kim JH; Yoon HK; Ko HK; Shin JH; Gwon DI
Korean J Radiol; 2019 Jan; 20(1):34-49. PubMed ID: 30627020
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience.
Idilman I; Peynircioğlu B; Cil BE; Doğanay Erdoğan B; Yalçın S; Bayraktar Y; Kav T; Altundağ K; Balkancı F
Turk J Gastroenterol; 2013; 24(2):141-7. PubMed ID: 23934461
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II study.
Nishiofuku H; Tanaka T; Matsuoka M; Otsuji T; Anai H; Sueyoshi S; Inaba Y; Koyama F; Sho M; Nakajima Y; Kichikawa K
J Vasc Interv Radiol; 2013 Jan; 24(1):56-65. PubMed ID: 23194749
[TBL] [Abstract][Full Text] [Related]
10. An investigation of efficacy, safety, and prognostic factors of drug-eluting beads-transarterial chemoembolization operation with CalliSpheres
Zhang X; Lin X; Qiu H; Peng Z
J Clin Lab Anal; 2019 Oct; 33(8):e22975. PubMed ID: 31328832
[TBL] [Abstract][Full Text] [Related]
11. Liver chemoembolization of hepatocellular carcinoma using TANDEM
Delicque J; Guiu B; Boulin M; Schwanz H; Piron L; Cassinotto C
Future Oncol; 2018 Nov; 14(26):2761-2772. PubMed ID: 29953255
[TBL] [Abstract][Full Text] [Related]
12. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization: current technique and future promise.
Liapi E; Georgiades CC; Hong K; Geschwind JF
Tech Vasc Interv Radiol; 2007 Mar; 10(1):2-11. PubMed ID: 17980314
[TBL] [Abstract][Full Text] [Related]
14. [Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) for metastatic liver tumors in patients with gastric cancer].
Hirasawa T; Asahara S; Fujisaki S; Kuraoka K; Takano K; Kamei A; Ikari T
Nihon Shokakibyo Gakkai Zasshi; 2008 Mar; 105(3):367-72. PubMed ID: 18332601
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Factors Affecting Clinical Response and Short-Term Survival to Drug-Eluting Bead Transarterial Chemoembolization for Treatment in Patients With Liver Cancer.
Wu X; Chen R; Zheng W; Hu H
Technol Cancer Res Treat; 2018 Jan; 17():1533033818759878. PubMed ID: 29739274
[TBL] [Abstract][Full Text] [Related]
16. Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.
Poggi G; Quaretti P; Minoia C; Bernardo G; Bonora MR; Gaggeri R; Ronchi A; Saluzzo CM; Azzaretti A; Rodolico G; Montagna M; Amatu A; Teragni C; Palumbo I; Traverso E; Tonini S; Villani L; Scelsi M; Baiardi P; Felisi MG; Sottotetti F; Tagliaferri B; Riccardi A
Anticancer Res; 2008; 28(6B):3835-42. PubMed ID: 19192637
[TBL] [Abstract][Full Text] [Related]
17. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
Pernot S; Artru P; Mithieux F; Marsot J; Watkin E; Pellerin O; Lledo G; Chalabreysse P; Desramé J; Taieb J
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):e73-7. PubMed ID: 26141343
[TBL] [Abstract][Full Text] [Related]
18. A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof.
Liu DM; Thakor AS; Baerlocher M; Alshammari MT; Lim H; Kos S; Kennedy AS; Wasan H
Future Oncol; 2015; 11(9):1421-8. PubMed ID: 25602287
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective.
Takayasu K
Jpn J Clin Oncol; 2012 Apr; 42(4):247-55. PubMed ID: 22407946
[TBL] [Abstract][Full Text] [Related]
20. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG
J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
